Why did a promising heart drug fail? Doomed drug highlights complications of meddling with cholesterol. 1.The failure of a high-profile cholesterol drug has thrown a spotlight on the complicated machinery that regulates cholesterol levels. But many researchers remain confident that drugs to boost levels of good cholesterol are still one of the most promising means to combat spiralling heart disease. 2.Drug company Pfizer announced on 2 December that it was cancelling all clinical trials of torcetrapib, a drug designed to raise heart-protective high-density lipoproteins (HDLs). In a trial of 15000 patients, a safety board found that more people died or suffered cardiovascular problems after taking the drug plus a cholesterol-lowering statin than those in a control group who took the statin alone. 3.The news came as a kick in the teeth to many cardiologists because earlier tests in animals and people suggested it would lower rates of cardiovascular disease. There have been no red flags to my knowledge, says John Chapman, a specialist in lipoproteins and atherosclerosis at the National Institute for Health and Medical Research (INSERM) in Paris who has also studied torcetrapib. This cancellation came as a complete shock. 4.Torcetrapib is one of the most advanced of a new breed of drugs designed to raise levels of HDLs, which ferry cholesterol out of artery-clogging plaques to the liver for removal from the body. Specifically, torcetrapib blocks a protein called cholesterol ester transfer protein (CETP), which normally transfers the cholesterol from high-density lipoproteins to low density, plaque-promoting ones. Statins, in contrast, mainly work by lowering the bad low-density lipoproteins. Under pressure 5.Researchers are now trying to work out why and how the drug backfired, something that will not become clear until the clinical details are released by Pfizer. One hint lies in evidence from earlier trials that it slightly raises blood pressure in some patients. It was thought that this mild problem would be offset by the heart benefits of the drug. But it is possible that it actually proved fatal in some patients who already suffered high blood pressure. If blood pressure is the explanation, it would actually be good news for drug developers because it suggests that the problems are specific to this compound. Other prototype drugs that are being developed to block CETP work in a slightly different way and might not suffer the same downfall. 6.But it is also possible that the whole idea of blocking CETP is flawed, says Moti Kashyap, who directs atherosclerosis research at the VA Medical Center in Long Beach, California. When HDLs excrete cholesterol in the liver, they actually rely on LDLs for part of this process. So inhibiting CETP, which prevents the transfer of cholesterol from HDL to LDL, might actually cause an abnormal and irreversible accumulation of cholesterol in the body. Youre blocking a physiologic mechanism to eliminate cholesterol and effectively constipating the pathway, says Kashyap. Going up 7.Most researchers remain confident that elevating high density lipoproteins levels by one means or another is one of the best routes for helping heart disease patients. But HDLs are complex and not entirely understood. One approved drug, called niacin, is known to both raise HDL and reduce cardiovascular risk but also causes an unpleasant sensation of heat and tingling. Researchers are exploring whether they can bypass this side effect and whether niacin can lower disease risk more than statins alone. Scientists are also working on several other means to bump up high-density lipoproteins by, for example, introducing synthetic HDLs. The only thing we know is dead in the water is torcetrapib, not the whole idea of raising HDL, says Michael Miller, director of preventive cardiology at the University of Maryland Medical Center, Baltimore.
英国:2017宝宝愈三成能到百岁
国际英语资讯:Cambodia, Sri Lanka sign 2 deals to boost bilateral ties
体坛英语资讯:Reigning champions China fall short of top artistic spot at FINA Worlds preliminaries
旧金山五名华人被杀,凶犯疑为死者中一人
面试时求职者最适合问的6种问题
上课打瞌睡有助记忆新知识
重口味街头人体雕塑:路人惊呼吓死爹了
让你重新专注起来工作的技巧
囧研究:小萝莉穿着性感会惹人厌?
美国发生iPhone4自燃爆炸事件
做好时间管理 告别拖拉懒散
窃贼和房主成十年至交好友
迪士尼将重拍《小鬼当家》等经典电影 期不期待?
婚前必须想清七大问题:别让自己嫁得不明不白
科学家发现脱发原因
美议员称中国打假不力危及美国
太空垃圾成隐患,宇航员进救生舱紧急避难
英国名字最长的村庄
银行满意度大调查农业银行垫底
英国驴友环非洲安然归来 爱车却在家门口被偷?!
奥巴马与俄总统私聊遭曝光 麦克风未关引风波
男子锯掉左脚逃避工作
阿富汗版花木兰:女儿当自强
愤怒也有好处? 生气的6大心理益处
《欲望都市》前传《凯莉日记》曝出新片场照
细节成就爱情:恋爱中需要注意的5大细节
美国婚礼花费排行 纽约六万美元居首
80岁时你会后悔的7件事:别等到老了再后悔
美俄总统私聊曝光 “转达给普京”网络走红
沙特或首次派女将出征奥运
不限 |
英语教案 |
英语课件 |
英语试题 |
不限 |
不限 |
上册 |
下册 |
不限 |